Atlas Trials

PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

Clinical trial NCT04142658 · TERMINATED

Trial details

NCT number
NCT04142658
Sponsor
Artivion Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Aortic Valve DiseaseAortic Valve StenosisAortic Valve Failure
Start date
2020-05-01
Primary completion
2022-12-12
Enrollment
863

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.